Medindia

X

FDA Issues Complete Response Letter for Ceftobiprole

Wednesday, December 30, 2009 Drug News J E 4
Advertisement

CONTACTS:

Media:  Ernie Knewitz, 908-927-2953 or Amy Firsching, 908-218-7583

Investor Relations:  Louise Mehrotra, 732-524-6491

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
2009 Great Year for Emergency Preparedness Busines...
S
syncreon Acquires NAL Worldwide Holdings Inc.